Patents by Inventor Dong Keun Hwang

Dong Keun Hwang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR PREVENTING OR TREATING MUSCLE DISEASE
    Publication number: 20250064867
    Abstract: The present invention relates to a method for improving muscle strength, and/or muscle mass by administering a composition containing as an active ingredient at least one selected from the group consisting of Akkermansia muciniphila cells, a culture thereof and a lysate thereof, and a method for preventing or treating muscle diseases where muscle strength and/or mass is weakened by sarcopenia, cachexia or muscle wasting.
    Type: Application
    Filed: September 18, 2024
    Publication date: February 27, 2025
    Applicant: KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY
    Inventors: Chul-Ho LEE, Byoung-Chan KIM, Yong-Hoon KIM, Jung-Ran NOH, Jae-Hoon KIM, Kyoung-Shim KIM, Dong-Hee CHOI, Young-Keun CHOI, Dong-Ho CHANG, Haiyoung JUNG, Jung Hwan HWANG
  • HETEROARYL DERIVATIVE COMPOUND AND USE THEREOF
    Publication number: 20240246940
    Abstract: The present invention relates to a heteroaryl derivative compound and a use thereof. The heteroaryl derivative of the present invention exhibits excellent inhibitory activity against HER2 and EGFR, and thus can be effectively used as a therapeutic agent for HER2- and/or EGFR-associated diseases.
    Type: Application
    Filed: April 8, 2022
    Publication date: July 25, 2024
    Inventors: Yi Kyung KO, Jin Hee PARK, Yeong Deok LEE, Hye Rim IM, Kyun Eun KIM, Dong Keun HWANG, Ah Reum HAN, Su Been NAM, Myung Hoe HEO, Eun Hwa KO, Hwan Geun CHOI, Sung Hwan KIM, Hong Ryul JUNG, Ji Hye YOO
  • HETEROARYL DERIVATIVE COMPOUND AND USE THEREOF
    Publication number: 20240067668
    Abstract: The present invention relates to a heteroaryl derivative compound and a use thereof. Since the heteroaryl derivative of the present invention exhibits excellent inhibitory activity against EGFR, the heteroaryl derivative can be usefully used as a therapeutic agent for EGFR-associated diseases.
    Type: Application
    Filed: December 29, 2021
    Publication date: February 29, 2024
    Inventors: Yi Kyung Ko, Ah Reum Han, Jin Hee Park, Yeong Deok Lee, Hye Rim Im, Kyun Eun Kim, Dong Keun Hwang, Su Been Nam, Myung Hoe Heo, Se Rin Cho, Eun Hwa Ko, Sung Hwan Kim, Hwan Geun Choi